Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Specialised Therapeutics to market Yondelis for PharmaMar

22 Oct 2019

Executive Summary

PharmaMar SA granted Specialised Therapeutics Asia Pte. Ltd. (STA) exclusive rights to market the sarcoma therapy Yondelis (trabectedin) in Australia, New Zealand, and Southeast Asia. (Former Yondelis licensee Janssen will continue to distribute the drug in Singapore, Malaysia and Brunei until STA formally takes over marketing authorization.)
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By